Showing results (91-100 of 214) with videos related to
Sort By:
Pageof 22
Advances in Experimental Medicine and Biology|January 1, 1989
Characterization of receptors for insulin and insulin-like growth factor-1 on FRTL-5 thyroid cellsN Perrotti, C M Rotella, F V Alvarez, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1986
Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' seraC M Rotella, R Zonefrati, R Toccafondi, et al.Acta Endocrinologica|January 1, 1986
Loss of adrenergic regulation of cAMP production in the FRTL-5 cell lineM L Brandi, C M Rotella, R Zonefrati, et al.Minerva Endocrinologica|March 4, 1999
[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data]F Galeone, G Fiore, A Arcangeli, et al.Andrology|October 2, 2014
Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic studyG Rastrelli, G Corona, E Mannucci, et al.Journal of Endocrinological Investigation|October 10, 2007
Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference?M Monami, N Marchionni, G Masotti, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 21, 2009
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysisM Monami, C Lamanna, N Marchionni, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 12, 2009
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trialsM Monami, I Iacomelli, N Marchionni, et al.International Journal of Andrology|February 20, 2009
Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseasesG Corona, E Mannucci, G Forti, et al.Diabetes, Obesity & Metabolism|August 29, 2012
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami, B Ahrén, I Dicembrini, et al.Pageof 22